A-Z Index
Instagram Facebook Twitter Youtube
Reporting LAHAN Alerts

COVID-19 Vaccine

Healthcare Provider Information Hub

Please refresh your browser to see the latest updates and versions of our documents.

New and Noteworthy - COVID-19 Vaccination

  • CDC/ISDA Webinar Ending of the COVID-19 Public Health Emergency & Other Related Changes 6-6-23 11am-12.15pm Subscribe | Recording
  • COVID-19 medical coverage changes following the end of the federal Public Health Emergency (05-23). CDPH table summarizes coverage for vaccines, therapeutics, and testing (for updated versions of this table, links to resources, and other information about impact of the end of multiple declarations, see slides/recordings of the CPDH provider vaccine/therapeutics webinars). See also FDA FAQs: What happens to EUAs when a public health emergency ends?
  • Webinar on Updated Recommendations for COVID-19 Vaccine Use. 5-11-23 See COCA website for slides and recording.
  • Janssen (Johnson & Johnson) COVID-19 vaccine no longer available in the US. All US government stock expired on 5-6-23. CDC recommends that people ages 18+ who received 1 or 2 J&J dose(s) receive 1 bivalent Moderna or Pfizer dose at least 2 months later.
  • CDPH COVID-19 Vaccine Timing Guide updated (5-5-23) English (Spanish translation pending)
  • New COVID-19 vaccine recommendations. Following FDA regulatory action, CDC simplified the COVID-19 vaccine recommendations on 4-19-23. In brief:
    • Everyone ages 6 years and older should receive a bivalent mRNA vaccine.
    • People ages 65 and older may get an additional bivalent mRNA vaccine at least 4 months after their first bivalent mRNA vaccine dose.
    • People who are immunocompromised may get an additional bivalent mRNA vaccine dose at least 2 months after their first bivalent dose. They may receive additional bivalent doses as needed.
  • COVID-19 Public Health Emergencies (PHEs) and Vaccines Under Emergency Use Authorization (EUA). Providers can still administer COVID-19 vaccines under EUA when the state and federal COVID-19 PHEs end. The FDA “EUA Declaration” remains in effect until terminated by the Health and Human Services Secretary; a date for this has not been announced. For further information, please visit FDA Emergency Use Authorization FAQs.

Becoming a COVID-19 Vaccination Provider

DPH greatly appreciates the partnership of health care providers and organizations to administer the COVID-19 vaccine to their patient population and their surrounding community members.

It is now easier to enroll and provide COVID-19 vaccinations –

  • Ultralow freezers are not required
  • Vaccine can be ordered in small quantities
  • Providers never need to miss a vaccination opportunity because of fear of vaccine wastage – some vaccine wastage is to be expected
  • Grants are available for providers enrolled in the Vaccines for Children program
  • Extensive support is available for start-up and beyond. DPH can offer one on one assistance with the enrollment process.

To learn more, view the flyers for Adult and Prenatal Providers and Pediatric Providers.

Detailed information regarding enrollment processes for joining the California COVID-19 Vaccination Program can be found at: https://eziz.org/covid/enrollment/.  The DPH Vaccination Partner Checklist has information and resources for providers offering COVID-19 vaccine.

Toolkit: Resources for Communicating with Parents & Children

This toolkit contains COVID-19 vaccine resources for patients (including fact sheets for parents and teens and activity sheets for children) along with provider resources (including sample letters) to support you when discussing and promoting COVID-19 vaccination to your patients.

Billing for Vaccinations Update

Providers cannot charge any out-of-pocket cost for COVID-19 vaccine. The vaccine must be made available at no cost to all individuals to ensure equitable access. Denying anyone vaccination or reducing appointments based on the person’s insurance status, charging for an office visit or other fee (if COVID-19 vaccination is the sole medical service provided), requiring additional medical services to receive COVID-19 vaccination, or seeking any additional reimbursement, including through balance billing from the vaccine recipient, is prohibited.

The loss of the HRSA COVID-19 Uninsured Program funding may prove a challenge to serving your neediest community members. Public Health is working hard to advocate with the federal and state government on your behalf. In the meantime, here are some considerations and resources to assist providers:

  • Providers may be able to bill Medicare, Medi-Cal or private insurance to obtain reimbursement for administering vaccines, and through other available mechanisms for the uninsured, where appropriate
  • California’s Department of Health Care Services will accept claims for individuals enrolled in the COVID-19 Uninsured Group Program. Individuals must apply for the COVID-19 Uninsured Group Program through a Medi-Cal Qualified Provider in the following programs: Presumptive Eligibility for Pregnant Women, Breast and Cervical Cancer Treatment Program, Hospital Presumptive Eligibility, and Child Health and Disability Prevention. Providers must submit applications via the COVID-19 Uninsured Group Application Portal.
  • Providers may refer any patient to a walk-in community vaccination site – they can visit the How to Get a Vaccine webpage or call the DPH Call Center at 833-540-0473 which is open 7 days a week from 8:00am-8:30pm for appointment or referral assistance
  • Providers may wish to hold onto records for possible future claim submission should the HRSA Uninsured Program receive funding and begin accepting claims, or another source of funding is established.
  • Billing and reimbursement webinar (4-29-22) from the California Department of Public Health and California Medical Association  Slides and recording.

Webinars and training series

  • CDPH California COVID-19 Vaccination Program Consolidated webinar (COVID-19 vaccine, COVID-19 therapeutics, Monkeypox)– Updates and Q&A Fridays 9am-10:30am Registration, slides & recordings
  • CDC COVID-19 Vaccine Webinar Series brief (15-20 minute) interactive modules that offer a real-world perspective on issues such as clinical and vaccine safety information, guidance for on-site clinic vaccination, and having conversations with vaccine recipients. Webinars
  • CDC Vaccine Training Modules (with CE) – Modules include a general overview of immunization practices regarding Pfizer, Moderna, and Novavax COVID-19 vaccines. Topics cover vaccine storage, handling, preparation, administration, and documentation. Modules
  • CDC COCA Webinars: Clinician Outreach and Communication Activity (COCA) Past COVID-19 topics include underlying medical conditions and severe COVID-19, vaccine safety and efficacy, and treating long COVID. Recorded webinars | Subscribe.
  • CDC/IDSA COVID-19 Clinician Calls: Monthly webinars (see webpage for dates). Recorded webinars | Subscribe.

Contact us about Vaccines

Vaccine Administration Provider Line -Questions about vaccine distribution, storage and handling, and guidance on registering to receive the vaccine through the CDPH enrollment website.

Vaccine Clinical Provider Line –Clinical questions about COVID-19 vaccines including but not limited to contraindications, precautions, side effects, post vaccination assessment

  • Monday through Friday, 8:00am-5:00pm, call 213-240-7941. For time-sensitive questions after hours, call 213-974-1234 and ask for the on-call clinician

CDC/CISAvax (Clinical Immunization Safety Assessment Project) - Consults about COVID-19 vaccine safety. Healthcare providers can request a consultation from CISA COVIDvax for a complex COVID-19 vaccine safety question that is (1) about an individual patient residing in the United States or vaccine safety issue and (2) not readily addressed by CDC or Advisory Committee on Immunization Practices (ACIP) guidelines. CISA has vaccine safety subject matter experts in multiple specialties (e.g. ID, allergy/immunology, neurology, OB/GYN, pediatrics, geriatrics)

  • Contact CDC_INFO: 800-CDC-INFO (800-232-4636) or online
  • In case of an emergent clinical COVID-19 vaccine safety inquiry, healthcare providers can call the CDC Emergency Operations Center (EOC) Watch Desk at (770)-488-7100. The EOC Watch Desk will route emergency inquiries to the CISA COVIDvax on-call staff.

Icon: Get Adobe Reader
Adobe Reader

Note: PDF documents on this site were created using Adobe Acrobat 5.0 or later. Document functionality may be reduced if you are using an earlier version (4.x or less). Get the latest version of Adobe Acrobat.

Public Health has made reasonable efforts to provide accurate translation. However, no computerized translation is perfect and is not intended to replace traditional translation methods. If questions arise concerning the accuracy of the information, please refer to the English edition of the website, which is the official version.

Los Angeles County Seal: Enriching lives through effective and caring services